Health
100 Most Popular
Most Popular Under $25

Aurora Cannabis

$9.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-1.51%) Today
-$0.10 (-1.02%) After Hours

Why Robinhood?

You can buy or sell ACB and other stocks, options, ETFs, and crypto commission-free!

About

Aurora Cannabis Inc. Common Shares, also called Aurora Cannabis, is a Canada-based company engaged in the production and distribution of medical cannabis. Read More The firm is vertically integrated and horizontally diversified across every key segment of the value chain; from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. Its purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The company also produces and sells indoor cultivation systems and hemp related food products. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Employees
967
Headquarters
Edmonton, Alberta
Founded
2006
Market Cap
9.79B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
12.38M
High Today
$9.95
Low Today
$9.51
Open Price
$9.78
Volume
17.01M
52 Week High
$12.53
52 Week Low
$4.05

Collections

Health
100 Most Popular
Most Popular Under $25
Pharmaceutical
Medical
Engineering
Food
2014 IPO

News

Seeking Alpha12h

What You Need To Know About Aurora Cannabis' Clinical Trials

Aurora Cannabis Inc (ACB) is a major Canadian cannabis producer operating across five continents. On February 11, 2019, ACB reported earnings for the quarter ending December 31, 2018. The company noted with earnings that it currently had "40 clinical trials and case studies completed or in progress," an achievement which forms part of the bull case on ACB. In this article I look into those clinical studies to see if there is indeed something to get excited about for ACB bulls or if these trials just represe...

9,002
Seeking Alpha13h

Aurora Cannabis' Investors Should Be Losing Sleep Over Its Dismal Financials

The winds of change are blowing as the coming financial quarters will see fundamentals increasingly take centre stage. Gross margins per gram is trending downwards on the back of an increase in the average selling price and cash costs per gram. Humpty Dumpty, the popular nursery rhyme taught to kids across the English speaking world foreshadows Aurora's (NYSE:ACB) future as the company continues along a trajectory characterized by substantial cash burn and a growing debt burden. Hence, while not fitting f...

16,697
InvestorPlace19h

Did You Miss Your Chance to Buy Aurora Cannabis (ACB) Stock?

Shares of Aurora Cannabis (NYSE: ACB ) have been soaring lately, up 25% in just a few trading sessions. Because of this giant move, investors are wondering if now’s the time to get in on ACB stock or if a 25% rally means they missed their chance. Source: Shutterstock What’s the verdict? I wouldn’t say there’s no upside left, but the risk-reward profile has certainly muddied. Unfortunately, investors who are suffering a case of FOMO — a “fear of missing out” — have no reason to be. There was ample time to...

28,727

Earnings

-$0.18
-$0.09
$0.00
$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.